Sheri Dubey

Years Active: 2019-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa M Plitnick, Beth Hutchins, Sheri Dubey, Nianyu Li, Rupesh P Amin, Stephanie Born, Ruban Mangadu, Joseph H Phillips, Venkataraman Sriram, Danuta J Herzyk
A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model. Journal of immunotoxicology 17 (1) (2021)
Igor Morozov, Thomas P Monath, David A Meekins, Jessie D Trujillo, Sun-Young Sunwoo, Kinga Urbaniak, In Joong Kim, Sanjeev K Narayanan, Sabarish V Indran, Wenjun Ma, William C Wilson, Cassandra O'Connor, Sheri Dubey, Sean P Troth, Beth-Ann Coller, Richard Nichols, Brian K Martin, Heinz Feldmann, Juergen A Richt
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerging microbes & infections 10 (1) (2021)
Susan B Manoff, Michele Sausser, Amy Falk Russell, Jason Martin, David Radley, Donna Hyatt, Christine C Roberts, Jason Lickliter, Janakan Krishnarajah, Andrew Bett, Sheri Dubey, Tyler Finn, Beth-Ann Coller
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Human vaccines & immunotherapeutics 15 (9) (2019)

Sheri Dubey.css-eqlu8i{font-size:small;padding-left:4px;}